UY30360A1 - Coterapeutica para el tratamiento de epilepsia y trastornos relacionados ii - Google Patents

Coterapeutica para el tratamiento de epilepsia y trastornos relacionados ii

Info

Publication number
UY30360A1
UY30360A1 UY30360A UY30360A UY30360A1 UY 30360 A1 UY30360 A1 UY 30360A1 UY 30360 A UY30360 A UY 30360A UY 30360 A UY30360 A UY 30360A UY 30360 A1 UY30360 A1 UY 30360A1
Authority
UY
Uruguay
Prior art keywords
related disorders
epilepsy
coterapeutics
treatment
effective amount
Prior art date
Application number
UY30360A
Other languages
English (en)
Inventor
Virginia L Smith-Swintosky
Bruce E Maryanoff
Allen B Reitz
Michael H Parker
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of UY30360A1 publication Critical patent/UY30360A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un método para el tratamietno de epilepsia y trastornos relacionados que comprede la administración a un sujeto que lo necesita de una coterapéutica con una cantidad terapéuticamente efectiva de un derivado de benzo-heteroarilsulfamida tal como se describe en la presente y una cantidad terapéuticamente efectiva de uno o varios agentes anticonvulsivantes y/o antiepilépticos.
UY30360A 2006-05-19 2007-05-22 Coterapeutica para el tratamiento de epilepsia y trastornos relacionados ii UY30360A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80200106P 2006-05-19 2006-05-19

Publications (1)

Publication Number Publication Date
UY30360A1 true UY30360A1 (es) 2007-08-31

Family

ID=38510389

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30360A UY30360A1 (es) 2006-05-19 2007-05-22 Coterapeutica para el tratamiento de epilepsia y trastornos relacionados ii

Country Status (7)

Country Link
US (1) US20070293476A1 (es)
AR (1) AR061066A1 (es)
CL (1) CL2007001468A1 (es)
PE (1) PE20080234A1 (es)
TW (1) TW200812574A (es)
UY (1) UY30360A1 (es)
WO (1) WO2007137164A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AR049646A1 (es) * 2004-06-16 2006-08-23 Janssen Pharmaceutica Nv Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
AU2006249577A1 (en) * 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US8497298B2 (en) * 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8492431B2 (en) * 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
JP2009537635A (ja) * 2006-05-19 2009-10-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 癲癇の処置のための共同−療法
EP2695618B2 (en) * 2006-06-15 2022-05-11 UCB Pharma GmbH Pharmaceutical composition comprising lacosamide and levetiracetam for use in the treatment of epilepsy
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
CA2729056A1 (en) 2008-06-23 2010-01-21 Janssen Pharmaceutica Nv Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
EP3193862B1 (en) 2014-09-16 2023-10-18 Igc Pharma Ip, Llc Topical cannabinoid composition for treating arthritic pain
EP3247359A4 (en) 2015-01-25 2018-08-08 India Globalization Capital, Inc. Composition and method for treating seizure disorders
WO2017027651A1 (en) 2015-08-12 2017-02-16 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
WO2017218629A1 (en) 2016-06-15 2017-12-21 India Globalization Capital, Inc. Method and composition for treating seizure disorders
RU2020128731A (ru) 2018-03-20 2022-04-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Средство для лечения эпилепсии
WO2024054807A1 (en) * 2022-09-06 2024-03-14 Biohaven Therapeutics Ltd. Combination therapies including metal channel activators and tdp-43 modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
WO1997019682A1 (en) * 1995-12-01 1997-06-05 Synaptic Pharmaceutical Corporation Aryl sulfonamide and sulfamide derivatives and uses thereof
DE60016602T2 (de) * 1999-08-20 2005-11-03 Ortho-Mcneil Pharmaceutical, Inc. Zusammensetzung enthaltend ein tramadol und ein antikonvulsives arzneimittel
CN1897950A (zh) * 2003-10-14 2007-01-17 惠氏公司 稠合芳基和杂芳基衍生物及其使用方法
WO2005079773A2 (en) * 2004-02-13 2005-09-01 Neuromolecular, Inc. Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders
MY142329A (en) * 2004-08-24 2010-11-15 Janssen Pharmaceutica Nv Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
US20070191460A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis

Also Published As

Publication number Publication date
CL2007001468A1 (es) 2008-04-04
WO2007137164A2 (en) 2007-11-29
TW200812574A (en) 2008-03-16
WO2007137164A3 (en) 2008-01-17
US20070293476A1 (en) 2007-12-20
AR061066A1 (es) 2008-07-30
PE20080234A1 (es) 2008-04-25

Similar Documents

Publication Publication Date Title
UY30360A1 (es) Coterapeutica para el tratamiento de epilepsia y trastornos relacionados ii
UY30359A1 (es) Coterapeutica para el tratamiento de epilepsia y trastornos relacionados i
GT200800138A (es) Combinacion de un inhibidor de acetilcolinesterasa y un agonista de 5-ht6 para el tratamiento de disfuncion cognitiva
CL2013003638A1 (es) Compuestos inhibidores de metaloenzimas; composición que comprende dichos compuestos; uso de la composición para tratar o prevenir una enfermedad asociada a metaloenzimas en plantas; uso para inhibir metaloenzimas en microorganismos y tratar un trastorno fúngico en plantas.
CR20120115A (es) Terapia de combinacion con composiciones de nanoparticulas de taxano e inhibidores de hedgehog
GT200600280A (es) Composiciones y metodos para el tratamiento de sintomas relacionados con el ciclo
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
RU2018145985A (ru) Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений
PA8778101A1 (es) Metodos y composiciones para tratar y monitorear el tratamiento de trastornos asociados con il-13
CR20150216A (es) Composiciones y métodos para tratar proteinopatías
EA201390707A1 (ru) Способ лечения контраст-индуцированной нефропатии
UY32989A (es) Coposiciones terapéuticas concentradas de fosfolípidos
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
ECSP088762A (es) Tratamiento del dolor
GT201200038A (es) Composicion para tratar la fibrosis quistica
ECSP12011962A (es) Tratamientos para trastornos gastrointestinales
UY30171A1 (es) Formas cristalinas de n- (benzo (b) tien-3-ilmetil) -sulfamida
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
MX2009005114A (es) Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus.
BR112012028451A2 (pt) composição tópica de iodopovidona
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
EP2547693A4 (en) INTEGRININE ACTION HEMMER FOR CANCER TREATMENT
IN2014CN04634A (es)
CL2012001031A1 (es) Compuestos derivados de 2-oxo-1-pirrolidinil-imidazotiadiazol; composición farmacéutica que los comprende; útiles para el tratamiento de la epilepsia, transtornos neurológicos, entre otros.
BR112012027080A2 (pt) composições orgânicas para tratar doenças relacionadas a beta - ena